Answers are grounded in this paper and cite their sources.
Preclinical animal study uncovers the pathogenic roles and protective efficacy of pneumococcal surface proteins in mice, highlighting their utility as candidate vaccine antigens.
Although the polysaccharide capsule has been recognized as a sine qua non of virulence, recent attention has focused on the role of pneumococcal proteins in pathogenesis, particularly in view of their potential as vaccine antigens. The contribution of pneumolysin, two distinct neuraminidases, autolysin, hyaluronidase, and the 37 kDa pneumococcal surface adhesin A has been examined by specifically mutagenizing the respective genes in the pneumococcal chromosome and examining the impact on virulence in animal models. The vaccine potential of these proteins has also been assessed by immunization of mice with purified antigens, followed by challenge with virulent pneumococci.
No takes yet. Share an insight, caveat, or question.
Paton et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: